Operating Principles Of The Device - Braster Pro User Manual

The Braster Pro is not intended for women who are undergoing or
have undergone breast cancer treatment, i.e. breast-conserving
surgery, mastectomy (unilateral or bilateral), systematic treatment
(chemotherapy, hormonal therapy, biological therapy) and
radiation therapy.
Temporary contraindications against using the Braster Pro:
• pregnancy or breastfeeding (up to three months after
weaning);
• general infection, with a body temperature of or in excess of
38˚C;
• breast infection with pain, skin redness and bruises (when the
said symptoms are present);
• inadequate temperature (too hot or too cold) in the room
where the examination is to be performed – the ambient
temperature must be between 20˚C and 25˚C;
• surgical procedure in the breast area with benign lesion
diagnosis:
- fine-needle biopsy (FNB) – up to four weeks after the
procedure,
- core-needle biopsy (CNB) or Mammotome's breast
biopsy – up to 6 months after the procedure,
- breast tumor resection – up to 12 months after the
procedure;
• aesthetic implant placement, filler injections (e.g. hyaluronic
acid) and lipotransfer – up to 12 months after the procedure.

2. OPERATING PRINCIPLES OF THE DEVICE

The Braster device uses a type of technology known as contact
thermography. Contact thermography is a medical imaging
technique for detecting changes in tissue metabolism. In medicine,
thermography is based on a phenomenon known as the "dermo-
thermal effect", in which the thermal processes that occur in the
organ examined (inside the body) manifest on the surface of the
13